Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin Gel for Infrabony Defects
NCT03677297Phase 4Completed
- Sponsor
- Dr. D. Y. Patil Dental College and Hospital
- Start
- Jan 2016
- Primary completion
- Aug 2017
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rosuvastatin 1.2% in situ gel in chronic periodontitis (2 arms), sponsored by Dr. D. Y. Patil Dental College and Hospital. Primary endpoint: Bone fill at 6 months. Started Jan 2016; status: completed.
02
Drugs
rosuvastatin 1.2% in situ gel
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT03677297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03677297.